Gamma Investing LLC Bristol Myers Squibb CO Transaction History
Gamma Investing LLC
- $18.8 Billion
- Q1 2025
A detailed history of Gamma Investing LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gamma Investing LLC holds 2,420,388 shares of BMY stock, worth $148 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
2,420,388
Previous 33,418
7142.77%
Holding current value
$148 Million
Previous $1.89 Billion
97.9%
% of portfolio
0.21%
Previous 0.16%
Shares
6 transactions
Others Institutions Holding BMY
# of Institutions
2,771Shares Held
1.56BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.68 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.86 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.8 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.68 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $130B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...